WO1997015268A1 - Formbandkalander - Google Patents

Formbandkalander Download PDF

Info

Publication number
WO1997015268A1
WO1997015268A1 PCT/EP1996/004600 EP9604600W WO9715268A1 WO 1997015268 A1 WO1997015268 A1 WO 1997015268A1 EP 9604600 W EP9604600 W EP 9604600W WO 9715268 A1 WO9715268 A1 WO 9715268A1
Authority
WO
WIPO (PCT)
Prior art keywords
rollers
product
pair
product mass
recesses
Prior art date
Application number
PCT/EP1996/004600
Other languages
German (de)
English (en)
French (fr)
Other versions
WO1997015268B1 (de
Inventor
Reinhard Spengler
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Priority to SK506-98A priority Critical patent/SK50698A3/sk
Priority to KR1019980702910A priority patent/KR19990066977A/ko
Priority to JP9516273A priority patent/JPH11514275A/ja
Priority to BR9611239A priority patent/BR9611239A/pt
Priority to AU74911/96A priority patent/AU705657B2/en
Priority to SI9620112A priority patent/SI9620112A/sl
Priority to EP96937213A priority patent/EP0957884A1/de
Publication of WO1997015268A1 publication Critical patent/WO1997015268A1/de
Publication of WO1997015268B1 publication Critical patent/WO1997015268B1/de
Priority to NO981795A priority patent/NO981795L/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B11/00Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/16Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using pocketed rollers, e.g. two co-operating pocketed rollers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/28Tabletting; Making food bars by compression of a dry powdered mixture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/10Moulding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B30PRESSES
    • B30BPRESSES IN GENERAL
    • B30B5/00Presses characterised by the use of pressing means other than those mentioned in the preceding groups
    • B30B5/04Presses characterised by the use of pressing means other than those mentioned in the preceding groups wherein the pressing means is in the form of an endless band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00General characteristics or adaptations
    • A61J2200/20Extrusion means, e.g. for producing pharmaceutical forms

Definitions

  • the present invention relates to a device and a method for producing flat shapes, in particular tablets, from a product mass containing active ingredients.
  • melt calendering A known method for the production of tablets is the so-called melt calendering. Such a process is described, for example, in DE-A-17 66 546 and US-A-4,880,585 b . The basis of this process is the embedding of an active ingredient in a melt from a carrier for
  • Example fatty substances or water-soluble, thermoplastic polymers The melt is produced by melting the mixture of active ingredient, polymer and optionally other auxiliaries, for example in an extruder, and shaping it as a melt in a downstream calender into tablets, which harden by cooling.
  • the molding calender comprises a pair of molding rollers rotating in opposite directions, the molding rollers having engravings (depressions) on their surface which correspond to the shape of half the desired tablet.
  • the tablets are formed in the contact area of the two rollers by connecting the tablet masses in the depressions of one roller with those in the opposite depressions of the other roller.
  • roller construction is very complex.
  • the depressions are milled into the rollers and in most cases have to be polished afterwards in order to get the tablet surface as smooth as possible.
  • the production of such rollers is very expensive because the recesses have to be made with great precision.
  • the rollers have to be adjusted so that always two recesses face each other as exactly as possible. This condition is particularly difficult to achieve if the depressions are very small.
  • Such a device is also inflexible because, for example, if you want to use the same device to produce different tablet shapes and / or sizes, this is only possible through a complete exchange of the rollers and a complex readjustment.
  • devices for tablet production are becoming large
  • the object of the present invention to provide a device for producing tablets which, on the one hand, is cheaper than the known devices and, on the other hand, offers greater flexibility.
  • the object of the invention is also to provide a simple and flexible method for tablet production.
  • a device for producing flat shapes from an active substance-containing product mass with at least one charging means for supplying the product mass, at least one pair of rollers, consisting of two counter-rotating calender rollers, the device being characterized in that it is a, preferably as Endless belt encircling forming belt, which is guided between the two rollers of a pair of rollers, the forming belt having recesses on its surface for receiving the product mass.
  • the rollers are arranged so that they have a gap-like passage between their lateral surfaces.
  • the smallest distance between the lateral surfaces of the pair of rollers essentially corresponds to the thickness of the forming strip.
  • the product mass preferably as a wide belt
  • the trough-like trough fed between the two rollers.
  • the forming belt and product ends are guided further into the area between the calender rolls, which is becoming ever narrower, the product mass being pressed into the recesses in the forming belt.
  • the distance between the rollers essentially determines the pressure that is exerted on the product mass and thus the density of the moldings thus produced.
  • Forming tapes made of plastic, in which the cutouts can be produced by molding are particularly inexpensive. Of course, care must be taken that the plastic is dimensionally stable at the temperatures that occur during tablet production.
  • the moldings formed in this way have a flat surface formed by the pressure roller, while the opposite surface is determined by the shape of the recess in the forming belt.
  • the cutouts are through openings in the forming band.
  • the openings are preferably produced by punching, any tablet shape being able to be produced depending on the punching tool used.
  • the product mass which is pressed into the molds during tablet production comes into contact with the two lateral surfaces of the pair of calender rolls, so that here Tablets are produced that have two flat surfaces.
  • cutouts or the openings in the forming belt are introduced in such a way that the product mass can be transferred into the product moldings with as little loss as possible.
  • Recesses or openings are preferred which have a round, oval or hexagonal shape when viewed from above.
  • the openings can also have webs on their circumferential surface, for example, which are produced by corresponding notches in the punching mold, so that tablets with broken notches can be produced.
  • the forming tape can be made from any material, but preferably from metal, particularly preferably from steel, plastic or rubber. If a molding tape made of a relatively rigid material is used, the thickness of the tape corresponds essentially to the desired thickness of the tablets. Thicker tablet forms therefore require a thicker belt, which can optionally be in the form of a link belt, so that it can be guided around the deflection rollers of the device more easily. However, it is also possible to use shaped tapes made of flexible material, which can then also be thicker than the desired thickness of the tablets. In this case, in particular, the forming belt is thicker than the gap between the calender rolls. When it is drawn in between the rollers, the forming belt is pressed ever further together, so that, depending on the distance between the calender rollers, a different pressure can be exerted on the tablet tablets.
  • the calender rolls preferably have smooth outer surfaces. If tablet moldings with an enlarged surface are required, then, for example, calender rolls are also conceivable, the surface of which has a certain roughness. Calender rolls which can be tempered are advantageously used. If a product mass is used that is plastic at high temperature and solidifies on cooling, it is preferred to work with cooled calender rolls. On the other hand, product masses are also known which are plastic in the moist state and solid in the dry state, so that in this case it is preferred to work with heatable calender rolls. The rollers therefore serve to cool or dry the product mass. Depending on the diameter of the rollers, the product mass has different lengths of thermal contact with these rollers.
  • the pressure rollers are universal tools that are preferably thermally conductive, stable under pressure and inert to the substances used. The distance between the rollers can be adjusted to generate different contact pressures.
  • the device has only one loading means for the product mass.
  • the product belts can be fed to a pair of rollers at the same time.
  • the distance between the pairs of rollers will preferably be set so that the contact pressure is lowest for the first pair of rollers and highest for the last pair of rollers.
  • the resulting tablets are then multi-layer tablets.
  • a thin protective film for example a diffusion-tight polymer in order to achieve a specific release of active ingredient.
  • Protective films can be produced that only dissolve under specific ambient conditions (for example with regard to pH or temperature) and release the active ingredient.
  • the coating can also serve as a taste or light protection. Should the entire tablet are covered with a protective film, this is generally carried out in a separate subsequent step using known coating processes.
  • the protective films on the top and bottom do not have to be identical. In the case of multilayer tablets, the protective films can, for example, lead to a different release of active ingredient.
  • Extruders and / or heatable filling wedges are used as preferred feed agents.
  • the device according to the invention tablets or pellet-like moldings can be produced continuously.
  • the device is extremely universal, since the basic roller device remains unchanged and only the forming belt has to be replaced. Depending on the ribbon used and the dimensions of the
  • the range of products that can be produced ranges from very small pellet-like products to tablet weights of 1 gram and more.
  • the moldings have edge angles of 90 ° or less, which, particularly in the case of brittle product masses, facilitates deburring of the tablets.
  • the openings in the forming belt are preferably spaced from one another, so that there is no twin formation of tablets during manufacture. A subsequent separation of the tablets is therefore not necessary.
  • the length of the forming belt can be varied within wide limits. It proves to be particularly advantageous that the residence time of the tablets in the molds can be extended as required, so that an ejection of not yet cooled (not yet cured) tablets is avoided.
  • the products can be removed from the forming belt in a simple manner by the roller deflection or, if appropriate, by using a spiked roller. This is particularly true in the case of shaped tapes with through openings, since here the tablets are accessible from the top and bottom and can be easily pushed out of the tape.
  • the flat moldings available with the forming calender are particularly suitable for use as tablets.
  • IR tablets in particular tablets that release the active ingredient quickly (instant release), SR tablets, i.e. Tablets with slow release of active ingredient (SJLow Release), prolonged-release tablets, i.e. Tablets with delayed release of active ingredients, sublingual tablets, the active ingredients of which are absorbed through the oral mucosa and which are therefore intended to dissolve "under the tongue", lozenges or dissolving tablets.
  • the tablets that can be produced in this way can of course not only be used in the pharmaceutical or food sector (e.g. in the form of vitamin tablets), but also applications in crop protection and in many areas of technology are conceivable.
  • the present invention also relates to a process for the production of flat moldings from an active substance-containing product mass, wherein a shaped strip provided with recesses is passed between the counter-rotating rollers of a pair of calender rollers, at least one product strand consisting of the active substance-containing mass, preferably as a wide strip, forms this Feeding the product strand to the pair of rollers, the product mass being pressed into the recesses between the rollers of the pair of rollers and the shaped articles being removed from the recesses after passing through the pair of rollers.
  • the desired contact pressure with which the product mass is compressed is set by the
  • the distance between the rollers ie the smallest distance between their lateral surfaces, should preferably not be greater than the thickness of the forming tape used.
  • the gap between the rollers can be selected to be significantly smaller than the thickness of the belt, so that a higher pressure can be exerted on the product mass.
  • the product strip is passed through several successive pairs of rollers. It is also possible to form a number of different product strands which are fed simultaneously to a pair of rollers or to a plurality of pairs of rollers in succession.
  • a multilayer melt can be produced by coextrusion, which already has the desired layer sequence of the later tablet in the melt.
  • the product mass is hot plastic or wet plastic.
  • the roller pairs will either be heated or cooled in order to obtain solid, dimensionally stable tablets.
  • the tablets are produced from a mixture which contains one or more active pharmaceutical ingredients and one or more customary auxiliaries and which, by melting or softening at least one component, becomes pasty to viscous and therefore extrudable.
  • mixtures which contain pharmacologically acceptable polymers for example polyvinylpyrrolidone (PVP), copolymers of N-vinylpyrrolidone (NVP) and vinyl acetate, copolymers of vinyl acetate and crotonic acid, partially saponified polyvinyl acetate, polyvinyl alcohol , Ethylene / vinyl acetate copolymers, polyhydroxyethyl methacrylate, copolymers of methyl methacrylate and acrylic acid, cellulose esters, cellulose ethers, polyethylene glycol or polyethylene.
  • PVP polyvinylpyrrolidone
  • NDP N-vinylpyrrolidone
  • VRP N-vinylpyrrolidone
  • vinyl acetate copolymers of vinyl acetate and crotonic acid
  • partially saponified polyvinyl acetate polyvinyl alcohol
  • Ethylene / vinyl acetate copolymers polyhydroxyethyl methacrylate
  • Fikentscher, Cellulose-Chemie 13 (1932), pages 58 to 64 and 71 and 74) of the polymers are in the range from 10 to 100, preferably 12 to 70, in particular 12 to 35, for PVP preferably at 12 to 35, especially at 12 to 17.
  • the polymeric binder must soften or melt in the total mixture of all components in the range from 50 to 180, preferably 60 to 130 ° C., so that the composition can be extruded.
  • the glass transition temperature of the mixture must therefore be below 180, preferably below 130 ° C.
  • plasticizing ancillary substances such as long chain alcohols, ethylene glycol, Propylen ⁇ , trimethylolpropane, triethylene glycol, butanediols, pentanols, hexanols, polyethylene glycols, silicones, aromatic Carbonsaureester (such as dialkyl phthalates, trimellitic esters, benzoic esters, terephthalic esters) or aliphatic dicarboxylic esters (eg Dialkyl adipates, sebacic acid esters, azelaic acid esters, citric and tartaric acid esters) or fatty acid esters.
  • plasticizing ancillary substances such as long chain alcohols, ethylene glycol, Propylen ⁇ , trimethylolpropane, triethylene glycol, butanediols, pentanols, hexanols, polyethylene glycols, silicones, aromatic Carbonsaureester (such as dialkyl phthalates
  • Common pharmaceutical auxiliaries the total amount of which can be up to 100% by weight, based on the polymer, are e.g.
  • Extenders or fillers such as silicates or silica, magnesium oxide, aluminum oxide, titanium oxide, stearic acid or their salts, e.g. the magnesium or calcium salt, methyl cellulose, sodium carboxymethyl cellulose, talc, sucrose, lactose, corn or corn starch, potato flour, polyvinyl alcohol, in particular in a concentration of 0.02 to 50, preferably 0.20 to 20,% by weight. %, based on the total weight of the mixture, are preferred;
  • Lubricants such as aluminum and calcium stearate, talc and silicone, in a concentration of 0.1 to 5, preferably 0.1 to 3% by weight, based on the total weight of the mixture, are preferred; Dyes, such as azo dyes, organic or inorganic pigments or dyes of natural origin, inorganic pigments in a concentration of 0.001 to 10, preferably 0.5 to 3% by weight, based on the total weight of the mixture;
  • Plasticizers such as animal or vegetable fats, especially in hydrogenated form and those which are solid at room temperature. These fats preferably have a melting point of 50 ° C or higher. Triglycerides of C 12 , C 14 , C 16 and C 18 fatty acids are preferred. Waxes such as carnauba wax can also be used. These fats and waxes can advantageously be admixed alone or together with mono- and / or diglycerides or phosphatides, in particular lecithin. The mono- and diglycerides are preferably those mentioned above
  • the total amount of fats, waxes, mono-, diglycerides and / or lecithins is 0.1 to 30, preferably 0.1 to 5% by weight, based on the total weight of the mass for the respective layer;
  • Stabilizers such as antioxidants, light stabilizers, hydroperoxide killers, radical scavengers, stabilizers against microbial attack.
  • wetting agents, preservatives, disintegrants, adsorbents, mold release agents and blowing agents can also be added (cf. e.g. H. Sucker et al. Pharmaceutical Technology, Thieme-Verlag, Stuttgart 1978).
  • auxiliaries are, for example, pentaerythritol and pentaerythritol tetraacetate, polymers such as polyethylene or polypropylene oxides and their block copolymers (poloxamers), phosphatides such as lecithin, homo- and copolymers of vinyl pyrrolidone, surfactants such as polyoxyethylene 40 stearate as well as citric and succinic acid, bile acids, sterols and others as for example given by JL Ford, Pharm. Acta Helv. 6_1, 69-88 (1986).
  • compositions in the sense of the invention are understood to mean all substances with a pharmaceutical effect and as few side effects as possible, provided that they do not decompose under the processing conditions.
  • the amount of active ingredient per dose unit and the concentration can vary within wide limits depending on the effectiveness and rate of release. The only requirement is that they are sufficient to achieve the desired effect.
  • the active substance concentration can be in the range from 0.1 to 95, preferably from 20 to 80, in particular 30 to 70% by weight.
  • Combinations of active substances, for example ibuprofen / caffeine can also be used.
  • Active substances in the sense of the invention are also vitamins and minerals, as well as plant treatment agents and insecticides.
  • the vitamins include the vitamins of the A group, the B group, meaning next to B ⁇ B 2, B 6 and B 12 i e nicotinic acid and nicotinamide sow also compounds with vitamin B properties are understood, such as adenine, choline, Pantothenic acid, biotin, adenylic acid, folic acid, orotic acid,
  • Active substances in the sense of the invention also include peptide therapeutic agents.
  • the method according to the invention is for example for processing suitable for the following active ingredients:
  • Cisplatin clarithromycin, clavulanic acid, clomibramine, clonazepam, clonidine, clotrimazole, codeine, cholestyramine, cromoglycine acid, cyanocobalamin, cyproterone, desogestrel, dexamethasone, dexpanthenol, dextrroethporphoxipod, dextro doproethoxamine, dextro dia methoxane, dextro dia methane pod
  • ron dihydroergotoxin diltiazem, diphenhydramine, dipyridamole, Dipy-, disopyramide, domperidone, dopamine, Doxocyclin, enalapril, ephedrine, epinephrine, ergocalciferol, ergotamine, erythromycin, estradiol, ethinylestradiol, etoposide, Eucalyptus globulus, famotidine, felodipine, fenofibrate, fenoterol, fentanyl , Flavin mononucleotide, fluconazole, flunarizine, fluorouracil, fluoXetin, flurbiprofen, furosemide, gallopamil, gemfibrozil, gentamicin, ginkgo biloba, glibenclamide, glipizide, clozapine, gly
  • Preferred active substances are ibuprofen, (as racemate, enantiomer or enriched enantiomer), ketoprofen, flurbiprofen, acetylsalicylic acid, verapamil, paracetamol, nifedipine or captopril.
  • solid solutions can be formed.
  • the term “solid solutions” is familiar to the person skilled in the art, for example from the literature cited at the beginning.
  • the active ingredient is molecularly dispersed in the polymer.
  • the pharmaceutical mixture is then melted in a conventional manner, preferably in an extruder, and fed to the forming belt calender, as is the case, for example, in US Pat. 4,880,585. If necessary, the tablets are cooled after calendering, for example in an air or cooling bath.
  • a mold release agent for example a silicone oil or a silicone varnish.
  • FIG. 1 shows a schematic view of the forming band calender according to the invention
  • FIG. 2 shows a detailed view in longitudinal section according to a first embodiment of the forming belt of the device from FIG. 1 carried out between the calender rolls,
  • Figure 3 is a view as in Figure 2 of a second embodiment of the forming belt.
  • FIG. 1 shows the forming belt calender 10 according to the invention, a forming belt 12 being guided between the calender rollers 14, 16 via deflection rollers 18.
  • An extruder 20 is used to produce the plastic product mass, which is preferably produced as a wide product band 22.
  • the width of the calender rolls 14, 16, the forming belt 12 and the product belt 22 are preferably essentially the same.
  • the direction of rotation of the forming belt 12 and the direction of rotation of the rollers 14 and 16 are indicated by arrows.
  • the product belt 22 is added parallel to the direction of movement of the forming belt 12 into the trough-like recess 26 between the rollers 14 and 16.
  • the forming tape 12 has depressions 24 or openings 30 on its surface, as in particular in FIGS. 2 and 3 is shown.
  • FIG. 2 shows a first embodiment of the device according to the invention, in which the forming belt 12 has depressions 24. Molding tape 12 and product mass 22 are carried in the increasingly narrow gap between the two rollers 14 and 16, the product mass 22 being pressed into the recesses 24 of the molding tape 12. If it is, for example, a product mass that is supplied in a hot, plastic state, at least one of the rollers 14, 16 can be cooled, so that the product mass cools down in the recesses 24 as it passes between the rollers, thereby producing solid moldings 28 which can then be removed from the recesses.
  • FIG. 3 shows the same detail as FIG. 2 of a forming band calender according to the invention according to FIG. 1, the forming band 12 in FIG. 3 according to another embodiment of the invention having through openings 30 into which the product mass 22 is pressed as it passes between the rollers 14 and 16 of the device becomes.
  • the moldings 28 produced in this case have two smooth surfaces.
  • the openings 30 in the forming band 12 are preferably created by punching out the forming band.
  • shaped articles 28 are formed, the edge angles of which are essentially 90 °. Any protruding product mass can be easily deburred with tablets shaped in this way.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Mechanical Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Manufacturing & Machinery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Casting Or Compression Moulding Of Plastics Or The Like (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PCT/EP1996/004600 1995-10-23 1996-10-23 Formbandkalander WO1997015268A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SK506-98A SK50698A3 (en) 1995-10-23 1996-10-23 Moulding strip calender
KR1019980702910A KR19990066977A (ko) 1995-10-23 1996-10-23 성형 스트립 캘린더
JP9516273A JPH11514275A (ja) 1995-10-23 1996-10-23 成形ベルトカレンダー
BR9611239A BR9611239A (pt) 1995-10-23 1996-10-23 Máquina e processo para produzir peças moldadas planas a partir de uma composição de produto contendo um ingrediente ativo
AU74911/96A AU705657B2 (en) 1995-10-23 1996-10-23 Molding belt calender
SI9620112A SI9620112A (sl) 1995-10-23 1996-10-23 Kalander z oblikovalnim trakom
EP96937213A EP0957884A1 (de) 1995-10-23 1996-10-23 Formbandkalander
NO981795A NO981795L (no) 1995-10-23 1998-04-22 Formst÷ping i en kalander

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19539359.7 1995-10-23
DE19539359A DE19539359A1 (de) 1995-10-23 1995-10-23 Formbandkalander

Publications (2)

Publication Number Publication Date
WO1997015268A1 true WO1997015268A1 (de) 1997-05-01
WO1997015268B1 WO1997015268B1 (de) 1997-06-05

Family

ID=7775506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/004600 WO1997015268A1 (de) 1995-10-23 1996-10-23 Formbandkalander

Country Status (16)

Country Link
EP (1) EP0957884A1 (sl)
JP (1) JPH11514275A (sl)
KR (1) KR19990066977A (sl)
CN (1) CN1200663A (sl)
AU (1) AU705657B2 (sl)
BR (1) BR9611239A (sl)
CA (1) CA2232353A1 (sl)
CZ (1) CZ109698A3 (sl)
DE (1) DE19539359A1 (sl)
HU (1) HUP9900734A3 (sl)
NO (1) NO981795L (sl)
SI (1) SI9620112A (sl)
SK (1) SK50698A3 (sl)
TW (1) TW343920B (sl)
WO (1) WO1997015268A1 (sl)
ZA (1) ZA968848B (sl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012051913A (ja) * 1999-10-13 2012-03-15 Novo Nordisk As 細長の剤形を製造する方法
WO2014139803A1 (en) * 2013-03-15 2014-09-18 AbbVie Deutschland GmbH & Co. KG Process and apparatus for metering a plasticized formulation

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751330A1 (de) * 1997-11-19 1999-05-20 Hosokawa Bepex Gmbh Formgebungsverfahren für bei Raumtemperatur knetbare, insbesondere zähelastische, klebrige Massen
DE19901383A1 (de) * 1999-01-15 2000-07-20 Knoll Ag Verfahren zur Herstellung unterschiedlicher fester Dosierungsformen
DE10007560C2 (de) * 1999-12-14 2002-09-26 Alexanderwerk Ag Vorrichtung zum Kompaktieren von kleinen Mengen pulverförmigen Materials
DE10038571A1 (de) * 2000-08-03 2002-02-14 Knoll Ag Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
NL2002672C2 (nl) * 2009-03-26 2010-09-28 Stork Titan Bv Massaverdeelinrichting en vorminrichting omvattende een dergelijke massaverdeelinrichting.
WO2012004408A2 (en) * 2010-07-09 2012-01-12 Research Center Pharmaceutical Engineering Multi-layer tablet formation by adhering tablet bodies together

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2157570A (en) * 1937-01-19 1939-05-09 Atlantic Coast Fisheries Co Apparatus for making tablets
FR1127146A (fr) * 1954-06-16 1956-12-10 Coal Industry Patents Ltd Appareil pour la fabrication des briquettes
DE1766546A1 (de) * 1968-06-11 1971-09-30 Eriksson Karl Gunnar Verfahren zur Herstellung von Arzneipillen oder Tabletten
CH530944A (de) * 1971-05-14 1972-11-30 Lonza Ag Verfahren zur Herstellung von Formstücken
US4880585A (en) * 1986-04-11 1989-11-14 Basf Aktiengesellschaft Continuous method of tableting
EP0358105A2 (de) * 1988-09-07 1990-03-14 BASF Aktiengesellschaft Verfahren und Vorrichtung zur kontinuierlichen Herstellung von festen pharmazeutischen Formen.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2157570A (en) * 1937-01-19 1939-05-09 Atlantic Coast Fisheries Co Apparatus for making tablets
FR1127146A (fr) * 1954-06-16 1956-12-10 Coal Industry Patents Ltd Appareil pour la fabrication des briquettes
DE1766546A1 (de) * 1968-06-11 1971-09-30 Eriksson Karl Gunnar Verfahren zur Herstellung von Arzneipillen oder Tabletten
CH530944A (de) * 1971-05-14 1972-11-30 Lonza Ag Verfahren zur Herstellung von Formstücken
US4880585A (en) * 1986-04-11 1989-11-14 Basf Aktiengesellschaft Continuous method of tableting
EP0358105A2 (de) * 1988-09-07 1990-03-14 BASF Aktiengesellschaft Verfahren und Vorrichtung zur kontinuierlichen Herstellung von festen pharmazeutischen Formen.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012051913A (ja) * 1999-10-13 2012-03-15 Novo Nordisk As 細長の剤形を製造する方法
WO2014139803A1 (en) * 2013-03-15 2014-09-18 AbbVie Deutschland GmbH & Co. KG Process and apparatus for metering a plasticized formulation

Also Published As

Publication number Publication date
ZA968848B (en) 1998-04-22
HUP9900734A2 (hu) 1999-10-28
CZ109698A3 (cs) 1999-07-14
DE19539359A1 (de) 1997-04-24
BR9611239A (pt) 1999-03-30
EP0957884A1 (de) 1999-11-24
TW343920B (en) 1998-11-01
NO981795D0 (no) 1998-04-22
HUP9900734A3 (en) 2000-07-28
AU705657B2 (en) 1999-05-27
JPH11514275A (ja) 1999-12-07
CN1200663A (zh) 1998-12-02
MX9802985A (es) 1998-09-30
KR19990066977A (ko) 1999-08-16
SI9620112A (sl) 1998-08-31
SK50698A3 (en) 1999-01-11
CA2232353A1 (en) 1997-05-01
NO981795L (no) 1998-04-23
AU7491196A (en) 1997-05-15

Similar Documents

Publication Publication Date Title
EP1237703B1 (de) Verfahren zum herstellen von festen wirkstoffhaltigen formen
EP0857062B1 (de) Verfahren zur herstellung von mehrschichtigen, festen arzneiformen zur oralen oder rektalen verabreichung
EP0799012B1 (de) Verfahren zur herstellung von umhüllten tabletten
EP0799013B1 (de) Verfahren zur herstellung von teilbaren tabletten
EP0864324B1 (de) Verfahren zur Herstellung von festen Kombinationsarzneiformen
EP0998920B1 (de) Verfahren zur Herstellung von festen Dosierungsformen
EP0993828B1 (de) Verfahren zur Herstellung von beschichteten festen Dosierungsformen
EP0820753A2 (de) Verfahren zur Herstellung von festen Arzneiformen
EP0998918B1 (de) Feste Dosierungsform mit copolymerem Bindemittel
EP1143910B1 (de) Verfahren und vorrichtung zur herstellung unterschiedlicher fester dosierungsformen
WO1997015268A1 (de) Formbandkalander
EP1848394B1 (de) Herstellung von dosierungsformen aus wirkstoffhaltigen schmelzen
WO1996019964A1 (de) Verfahren zur herstellung von linsenförmigen tabletten durch schmelzkalandrierung
EP1133271B1 (de) Verfahren zur herstellung von festen dosierungsformen
EP0922462A2 (de) Verfahren zur Herstellung von festen Dosierungsformen
EP0931552A2 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE19539363A1 (de) Verfahren zur Herstellung von festen Arzneiformen
EP0998919A2 (de) Feste Dosierungsform mit copolymerem Bindemittel
MXPA98002985A (en) Press rollers with tape for mold

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96197806.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN CZ HU IL JP KR MX NO RU SI SK US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PV1998-1096

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/002985

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2232353

Country of ref document: CA

Ref document number: 2232353

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 50698

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1996937213

Country of ref document: EP

Ref document number: 1019980702910

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 1997 516273

Country of ref document: JP

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: PV1998-1096

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019980702910

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1996937213

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1998-1096

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1996937213

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019980702910

Country of ref document: KR